查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美器官保存解決方案市場預測至 2028 年 - COVID-19 影響和區域分析 - 按類型、應用程式、器官類型和最終用戶
市場調查報告書
商品編碼
1375183

北美器官保存解決方案市場預測至 2028 年 - COVID-19 影響和區域分析 - 按類型、應用程式、器官類型和最終用戶

North America Organ Preservation Solutions Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, Organ Type, and End User
出版日期: | 出版商: The Insight Partners | 英文 146 Pages | 訂單完成後即時交付

價格

北美器官保存解決方案市場預計將從2023年的1.2036億美元成長到2028年的1.7718億美元。預計2023年至2028年的年複合成長率為8.0%。

導致腎衰竭的慢性病盛行率不斷增加，推動北美器官保存解決方案市場成長

腎臟移植是全球最常見的器官移植。根據器官採購和移植網路（OPTN）的數據，2021年美國進行了41,354例器官移植，比2020年成長5.9%。其中腎臟移植總數為24,669例，肝臟移植總數為9,236例，心臟移植總數為3,817例。

慢性腎臟病 (CKD) 是一種常見且可能致命的疾病，影響全球大約每十個人中就有一個。此外，美國國家腎臟基金會發表的一項研究預測，20歲以上的糖尿病族群隨著時間的推移將患上慢性腎病。

美國國家腎臟基金會報告稱，預計 2021 年 CKD 導致的死亡人數將超過前列腺癌或乳腺癌。這是一種未被廣泛認知的緊急健康狀況。

根據美國疾病管制與預防中心 (CDC) 2020 年的估計，三分之一的糖尿病成人和五分之一的高血壓成人可能患有慢性腎臟病。根據 CDC 2021 年發布的報告，美國每年約有 15% 的人患有慢性腎臟病。

國家腎臟基金會表示，腎臟受損的人並不知道患有慢性腎臟疾病，這顯示腎臟疾病市場的潛在市場潛力。預計這些因素將在預測期內促進市場成長。

北美器官保存解決方案市場概況

基於美國、加拿大和墨西哥三個主要國家對北美器官保存解決方案市場進行分析。由於器官移植的增加和老年人口的增加等因素，美國在器官保存解決方案市場中佔有最大佔有率。

在北美，美國是器官保存解決方案的最大市場。美國慢性腎臟病盛行率的增加和老年人口的增加可能會加速該市場的發展。例如，根據國家慢性腎臟病情況說明書，2021 年，美國約有 3,700 萬人患有慢性腎臟病。此外，根據美國腎臟基金會的數據，約有81萬美國人患有腎衰竭，其中57萬名患者正在接受透析，24萬名患者接受了腎臟移植。此外，根據 CDC 的數據，慢性腎臟病 (CKD) 在 65 歲或以上人群 (38%) 中比 45-64 歲人群 (12%) 或 18-44 歲人群 (6%) 更常見。尊重當前的估計。此外，隨著 CKD 在美國的盛行率不斷增加，與 CKD 相關的健康問題隨著時間的推移而惡化。它還會增加心臟病和中風的機會。因此，由於這些事實，未來幾年腎臟移植病例可能會增加。此外，FDA 批准的增加以及該地區主要市場參與者的存在正在推動市場成長。例如，2022 年 4 月，TransMedics Group, Inc. 的 OCS 心臟系統獲得了美國食品藥物管理局 (FDA) 的上市前批准，可用於循環死亡 (DCD) 捐贈者的器官。

北美器官保存解決方案市場收入及2028年預測（百萬美元）

北美器官保存解決方案市場細分

北美器官保存解決方案市場按類型、應用、器官類型、最終用戶和國家進行細分。

根據類型，北美器官保存溶液市場分為威斯康辛大學溶液、custodiol htk、perfadex、hyperthermosol 等。威斯康辛大學解決方案部門於 2023 年佔據北美器官保存解決方案市場佔有率最大的佔有率。

根據應用，北美器官保存解決方案市場分為靜態冷藏、低溫機器灌注、常溫機器灌注等。 2023 年，靜態冷藏領域佔據北美器官保存解決方案最大市場。

根據器官類型，北美器官保存解決方案市場分為腎臟、肝臟、肺臟、心臟等。 2023 年，腎臟細分市場佔據北美最大的器官保存解決方案市場。

根據最終用戶，北美器官保存解決方案市場分為器官移植中心、醫院和專科診所。到 2023 年，器官移植中心細分市場將佔據北美器官保存解決方案最大的市場。

按國家分類，北美器官保存解決方案市場分為美國、加拿大和墨西哥。 2023年，美國在北美器官保存解決方案市場佔有率中佔據主導地位。

21世紀醫學；雅閣醫療保健；生命之橋有限公司； Franz Koehler Chemie GmbH 博士；生命線科學公司；有機氧化有限公司； Paragonix 技術公司；保存解決方案公司；跨醫療機構；沃特世醫療系統有限責任公司；和 XVIVO Perfusion 是該地區北美器官保存解決方案市場的領導公司。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 北美器官保存解決方案市場 - 按類型
    • 北美器官保存解決方案市場 - 按應用
    • 北美器官保存解決方案市場 - 按器官類型
    • 北美器官保存解決方案市場 - 按最終用戶分類
    • 北美器官保存解決方案市場 - 按國家/地區

第 2 章：北美器官保存解決方案市場 - 要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美器官保存解決方案市場 - 市場格局

  • 概述
  • PEST分析
    • 北美 - PEST 分析
  • 專家意見

第 5 章：北美器官保存解決方案市場 - 主要市場動態

  • 市場促進因素
    • 器官移植的需求不斷增加
    • 導致腎衰竭的慢性病盛行率不斷增加
    • 老年人口增加
  • 市場限制
    • 昂貴的器官移植手術
    • 器官移植手術捐贈者數量有限
  • 市場機會
    • 心血管疾病 (CVD) 盛行率上升
  • 未來的趨勢
    • 新興國家的成長機會
  • 影響分析

第 6 章：器官保存解決方案市場 - 北美分析

  • 北美器官保存解決方案市場收入預測與分析

第 7 章：北美器官保存解決方案市場 - 2028 年收入與預測 - 按類型

  • 概述
  • 威斯康辛大學解決方案 (UW) 市場
  • 保管二醇 HTK
  • 佩法迪克斯
  • 低溫溶膠
  • 其他

第 8 章：北美器官保存解決方案市場 - 2028 年收入和預測 -按應用

  • 概述
  • 2022 年和 2028 年北美器官保存解決方案市場佔有率，按應用分類 (%)
  • 靜態冷庫
  • 低溫灌注機
  • 常溫機器灌注
  • 其他

第 9 章：北美器官保存解決方案市場 - 2028 年收入和預測 - 按器官類型

  • 概述
  • 2022 年和 2028 年北美器官保存解決方案市場佔有率，按器官類型分類（%）
  • 心
  • 肺
  • 腎
  • 肝
  • 其他

第 10 章：北美器官保存解決方案市場 - 收入和 2028 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2028 年北美器官保存解決方案市場佔有率（按最終用戶）（%）
  • 器官移植中心
  • 醫院
  • 專科診所

第 11 章：北美器官保存解決方案市場 - 2028 年收入與預測 - 國家分析

  • 北美：器官保存解決方案市場
    • 概述

第 12 章：北美器官保存解決方案市場-產業格局

  • 概述
  • 器官保存解決方案市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 13 章：公司簡介

  • Waters Medical Systems LLC
  • XVIVO Perfusion
  • TransMedics
  • OrganOx Limited
  • Paragonix Technologies, Inc
  • Dr. Franz Koehler Chemie GmbH
  • Accord Healthcare
  • ST CENTURY MEDICINE
  • Bridge to Life Ltd
  • Preservation Solutions, Inc.
  • Lifeline Scientific, Inc.

第 14 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: TIPRE00025778

The North America organ preservation solutions market is expected to grow from US$ 120.36 Million in 2023 to US$ 177.18 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.

Increasing Prevalence of Chronic Diseases Leading to Kidney Failure Fueling North America Organ Preservation Solutions Market Growth

A kidney transplant is the most common organ transplant globally. According to the Organ Procurement and Transplantation Network (OPTN), in 2021, 41,354 organ transplants were performed in the US, an increase of 5.9% over 2020. There were a total of 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants.

Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately one in every ten people worldwide. Additionally, a study published by the National Kidney Foundation predicted that the diabetic population over the age of 20 would develop chronic kidney disease over time.

The National Kidney Foundation reported that CKD is expected to kill more people in 2021 than prostate or breast cancer. It is a widely under-recognized emergency health condition.

According to the estimates given by the Centers for Disease Control and Prevention (CDC) in 2020, 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease. According to the CDC report issued in 2021, ~15% of people in the US suffer from chronic renal disease each year.

The National Kidney Foundation states that people with kidney damage are unaware of having chronic kidney disease, which indicates the underlying market potential in the kidney disease market. These factors are expected to enhance market growth during the forecast period.

North America Organ Preservation Solutions Market Overview

The North America organ preservation solution market is analyzed based on three major countries: the US, Canada, and Mexico. The US holds the largest share of the organ preservation solution market owing to factors such as the increasing organ transplantation and growing geriatric population.

In North America, the US is the largest market for organ preservation solutions. Increasing prevalence of chronic kidney diseases and growing geriatric population in the US are likely to accelerate the development of this market. For instance, according to the National Chronic Kidney Disease fact sheet, in 2021, ~37 million people had chronic kidney diseases in the US. Furthermore, according to the American Kidney Fund, Inc, ~810,000 Americans have kidney failure, of which 570,000 patients are undergoing dialysis, and 240,000 have undergone kidney transplantation. In addition, according to the CDC, chronic kidney disease (CKD) is more common in people aged 65 years or older (38%) than in people aged 45-64 years (12%) or 18-44 years (6%) with respect to the current estimate. Moreover, with the increasing prevalence of CKD in the US, CKD-related health problems worsen over time. It also increases the chances of having heart disease and stroke. Thus, owing to these facts, the cases of kidney transplantations are likely to increase in the coming years. Moreover, the rise in FDA approvals and the presence of the major market players in the region are boosting the market growth. For instance, in April 2022, TransMedics Group, Inc. received premarket U.S. Food and Drug Administration (FDA) approval of its OCS Heart System for use with organs from donors after circulatory death (DCD).

North America Organ Preservation Solution Market Revenue and Forecast to 2028 (US$ Million)

North America Organ Preservation Solution Market Segmentation

The North America organ preservation solution market is segmented into type, application, organ type, end user, and country.

Based on type, the North America organ preservation solution market is segmented into University of Wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The University of Wisconsin solution segment registered the largest North America organ preservation solution market share in 2023.

Based on application, the North America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest North America organ preservation solution market share in 2023.

Based on organ type, the North America organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest North America organ preservation solution market share in 2023.

Based on end user, the North America organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest North America organ preservation solution market share in 2023.

Based on country, the North America organ preservation solutions market has been categorized into the US, Canada, and Mexico. The US dominated the North America organ preservation solutions market share in 2023.

21ST CENTURY MEDICINE; Accord Healthcare; Bridge to Life Ltd; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; OrganOx Limited; Paragonix Technologies, Inc; Preservation Solutions, Inc.; TransMedics; Waters Medical Systems LLC; and XVIVO Perfusion are the leading companies operating in the North America organ preservation solutions market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America organ preservation solution market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America organ preservation solution market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the organ preservation solution market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Organ Preservation Solution Market - by Type
    • 1.3.2 North America Organ Preservation Solution Market - by Application
    • 1.3.3 North America Organ Preservation Solution Market - by Organ Type
    • 1.3.4 North America Organ Preservation Solution Market - by End User
    • 1.3.5 North America Organ Preservation Solution Market - by Country

2. North America Organ Preservation Solution Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Organ Preservation Solution Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
  • 4.3 Expert Opinions

5. North America Organ Preservation Solution Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Need for Organ Transplantation
    • 5.1.2 Increasing Prevalence of Chronic Diseases Leading to Kidney Failure
    • 5.1.3 Rising Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Expensive Organ Transplant Surgeries
    • 5.2.2 Limited Number of Donors for Organ Transplant Surgeries
  • 5.3 Market Opportunities
    • 5.3.1 Rising Prevalence of Cardiovascular Diseases (CVDs)
  • 5.4 Future Trends
    • 5.4.1 Growth Opportunities in Emerging Nations
  • 5.5 Impact Analysis

6. Organ Preservation Solution Market - North America Analysis

  • 6.1 North America Organ Preservation Solutions Market Revenue Forecast and Analysis

7. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
    • 7.1.1 North America Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
  • 7.2 University of Wisconsin Solution (UW) Market
    • 7.2.1 Overview
    • 7.2.2 University of Wisconsin solution (UW) :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.3 Custodiol HTKs
    • 7.3.1 Overview
    • 7.3.2 Custodiol HTKs :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.4 Perfadex
    • 7.4.1 Overview
    • 7.4.2 Perfadex : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.5 Hypothermosol
    • 7.5.1 Overview
    • 7.5.2 Hypothermosol : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)

8. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Application

  • 8.1 Overview
  • 8.2 North America Organ Preservation Solutions Market Share, by Application, 2022 and 2028 (%)
  • 8.3 Static Cold Storage
    • 8.3.1 Overview
    • 8.3.2 Static Cold Storage: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.4 Hypothermic Machine Perfusion
    • 8.4.1 Overview
    • 8.4.2 Hypothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.5 Normothermic Machine Perfusion
    • 8.5.1 Overview
    • 8.5.2 Normothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)

9. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by Organ Type

  • 9.1 Overview
  • 9.2 North America Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
  • 9.3 Heart
    • 9.3.1 Overview
    • 9.3.2 Heart: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.4 Lung
    • 9.4.1 Overview
    • 9.4.2 Lung: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.5 Kidney
    • 9.5.1 Overview
    • 9.5.2 Kidney: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.6 Liver
    • 9.6.1 Overview
    • 9.6.2 Liver: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)

10. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 - by End User

  • 10.1 Overview
  • 10.2 North America Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
  • 10.3 Organ Transplant Centres
    • 10.3.1 Overview
    • 10.3.2 Organ Transplant Centres : North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 10.4 Hospitals
    • 10.4.1 Overview
    • 10.4.2 Hospitals: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • 10.5 Specialty Clinics
    • 10.5.1 Overview
    • 10.5.2 Specialty Clinics: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)

11. North America Organ Preservation Solution Market - Revenue and Forecast to 2028 -Country Analysis

  • 11.1 North America: Organ Preservation Solution Market
    • 11.1.1 Overview
      • 11.1.1.1 United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.1.3 United States: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.1.4 United States: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.1.5 United States: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.1.6 United States: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)
      • 11.1.1.2 Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.2.3 Canada: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.2.4 Canada: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.2.5 Canada: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.2.6 Canada: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)
      • 11.1.1.3 Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 11.1.1.3.3 Mexico: Organ Preservation Solution Market, by Type, 2020-2028 (US$ Thousand)
        • 11.1.1.3.4 Mexico: Organ Preservation Solution Market, by Application, 2020-2028 (US$ Thousand)
        • 11.1.1.3.5 Mexico: Organ Preservation Solution Market, by Organ Type, 2020-2028 (US$ Thousand)
        • 11.1.1.3.6 Mexico: Organ Preservation Solution Market, by End User, 2020-2028 (US$ Thousand)

12. North America Organ Preservation Solution Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Organ Preservation Solutions Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Waters Medical Systems LLC
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 XVIVO Perfusion
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 TransMedics
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 OrganOx Limited
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Paragonix Technologies, Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Dr. Franz Koehler Chemie GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Accord Healthcare
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8ST CENTURY MEDICINE
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Bridge to Life Ltd
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Preservation Solutions, Inc.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Lifeline Scientific, Inc.
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. United States Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 2. United States Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 3. United States Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 4. United States Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 5. Canada Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 6. Canada Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 7. Canada Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 8. Canada Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 9. Mexico Organ Preservation Solution Market, by Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 10. Mexico Organ Preservation Solution Market, by Application - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 11. Mexico Organ Preservation Solution Market, by Organ Type - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 12. Mexico Organ Preservation Solution Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 13. Recent Inorganic Growth Strategies in the Organ Preservation Solutions Market
  • Table 14. Recent Organic Growth Strategies in the Organ Preservation Solutions Market
  • Table 15. Glossary of Terms

List Of Figures

  • Figure 1. North America Organ Preservation Solution Market Segmentation
  • Figure 2. North America Organ Preservation Solution Market, by region
  • Figure 3. North America Organ Preservation Solution Market Overview
  • Figure 4. University of Wisconsin solution (UW) Segment Held Largest Share of Type Segment in North America Organ Preservation Solution Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America PEST Analysis
  • Figure 7. North America Organ Preservation Solutions Market Impact Analysis of Drivers and Restraints
  • Figure 8. North America Organ Preservation Solutions Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 9. North America Organ Preservation Solutions Market, By Type 2022 & 2028 (%)
  • Figure 10. University of Wisconsin solution (UW) :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 11. Custodiol HTKs :North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 12. Perfadex : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 13. Hypothermosol : North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 14. Others: North America Organ Preservation Solutions Market Revenue and Forecasts to 2028 (US$ Thousand)
  • Figure 15. Medical devices market Share, by Application, 2022 and 2028 (%)
  • Figure 16. Static Cold Storage: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 17. Hypothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 18. Normothermic Machine Perfusion: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 19. Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 20. North America Organ Preservation Solutions Market Share, by Organ Type, 2022 and 2028 (%)
  • Figure 21. Heart: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 22. Lung: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 23. Kidney: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 24. Liver: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 25. Others: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 26. North America Organ Preservation Solutions Market Share, by End User, 2022 and 2028 (%)
  • Figure 27. Organ Transplant Centers: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 28. Hospitals: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 29. Specialty Clinics: North America Organ Preservation Solutions Market- Revenue and Forecast to 2028 (USD Thousand)
  • Figure 30. North America: Organ Preservation Solution Market, by Key Country - Revenue (2022) (US$ Thousand)
  • Figure 31. North America: Organ Preservation Solution Market, by Country, 2022 & 2028 (%)
  • Figure 32. United States: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 33. Canada: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 34. Mexico: Organ Preservation Solution Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 35. Growth Strategies in the Organ Preservation Solutions Market